Ziyang First People's Hospital Trials

Ziyang First People's Hospital	Welcome, Profile Billing Logout

63 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Wang, Li Yong

DEFORM, NCT05606718: Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Remodeling

Recruiting

RoW

Dapagliflozin, guideline-directed medical therapy (GDMT)

Sun Yat-sen University

Functional Mitral Regurgitation

06/23

07/23

ERSAF, NCT03749057: Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation

Recruiting

400

RoW

Rivaroxaban

General Hospital of Shenyang Military Region

Cerebral Infarction, TIA

11/24

DCAP, NCT04868565: Target Weaning Oxygen to Determine Cafffeine Duration for AOP

Completed

310

RoW

Caffeine Citrate 20 MG/1 ML Intravenous Solution [CAFCIT]

Children's Hospital of Chongqing Medical University

Apnea of Prematurity, Caffeine, Weaning Oxygen, Medicine Regimen

10/23

NCT06461377: The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy

Recruiting

RoW

Glucagon-like peptide-1 receptor agonist：Semaglutide, Semaglutide

The First Affiliated Hospital with Nanjing Medical University

Type 2 Diabetes, Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)

12/26

12/27

NCT06359106: Effects of Different Inhaled Oxygen Concentrations on Lung Function in Older Patients After Laparoscopic Gastrointestinal Surgery Under General Anesthesia

Recruiting

1098

RoW

80% Oxygen, 40% Oxygen

China Medical University, China

Oxygenation Index

12/25

NCT04650243: Clinical Research of Tapering UDCA in PBC Patients with a Complete Response

Recruiting

RoW

ursodeoxycholic acid, UDCA

Peking Union Medical College Hospital

Primary Biliary Cholangitis

05/25

NCT06674226: Effects of Ciprofol on Postoperative Delirium and Outcomes in Elderly Patients Undergoing Major Thoracic Surgery

Recruiting

214

RoW

Ciprofol, Propofol

Wang Tianlong, Xiangya Hospital of Central South University, The Third Xiangya Hospital of Central South University, The First Hospital of Hebei Medical University, The First Affiliated Hospital of Nanchang University, Tongji Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Postoperative Delirium (POD)

06/26

EM-PD, NCT06928519: Efficacy and Safety of Entacapone Combined With Madopar in the Treatment of Early Parkinson's Disease: An Observational, Multicenter, Case-Control Study

Recruiting

216

RoW

Madopar (levodopa/benserazide), Intervention for Madopar + Entacapone Group

Yousheng Xiao, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Guangxi International Zhuang Medicine Hospital, Ethnic Hospital of Guangxi Zhuang Autonomous Region, Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University

Parkinson Disease (PD)

04/27

06/27

NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting

9000

RoW

Aspirin 100 mg Oral Tablet, Matching Placebo

Guangdong Provincial People's Hospital, The George Institute

CKD (Chronic Kidney Disease) Stage 5D

09/26

12/26

NCT02654561: Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation

Recruiting

600

RoW

Heparin Sodium, Unfractionated heparin, Saline, Normal saline

China Medical University, China, West China Hospital, Zhongda Hospital, The First Affiliated Hospital of Dalian Medical University, Shengjing Hospital, The First Hospital of Jilin University, Qilu Hospital of Shandong University, The Second Affiliated Hospital of Kunming Medical University, The First Hospital of Qinhuangdao, The Second Affiliated Hospital of Dalian Medical University, First Affiliated Hospital of Harbin Medical University, Peking University People's Hospital, The People's Hospital of Liaoning Province, Fourth People's Hospital of Shenyang, Beijing Tsinghua Changgeng Hospital, First Affiliated Hospital of Kunming Medical University, The Affiliated Hospital of Qingdao University, Beijing Friendship Hospital, General Hospital of Ningxia Medical University, The First Affiliated Hospital of Nanchang University

Sepsis, Disseminated Intravascular Coagulation

12/24

06/25

EHTASEOCCS, NCT03373058: Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery

Recruiting

310

RoW

Hyperthermic Intraperitoneal Chemotherapy, HIPEC, cytoreductive surgery, CRS, adjuvant chemotherapy, ACT

Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, Henan Provincial People's Hospital, Xiangya Hospital of Central South University, The Third Xiangya Hospital of Central South University, Peking University Cancer Hospital & Institute, Peking University People's Hospital, Cancer Hospital of Guizhou Province, Chinese PLA General Hospital, Hebei Medical University Fourth Hospital, The Second Hospital of Hebei Medical University, West China Second University Hospital, Peking Union Medical College Hospital, First Affiliated Hospital, Sun Yat-Sen University, Henan Cancer Hospital, Tianjin Medical University Cancer Institute and Hospital, The Third Affiliated Hospital of Guangzhou Medical University, Wuhan University, RenJi Hospital, Obstetrics & Gynecology Hospital of Fudan University, Southern Medical University, China, Fourth Affiliated Hospital of Guangxi Medical University, Shandong Cancer Hospital and Institute, Beijing Obstetrics and Gynecology Hospital, Chongqing University Cancer Hospital, Xinqiao Hospital of Chongqing, Wuhan Union Hospital, China, First Affiliated Hospital of Chongqing Medical University, Affiliated Cancer Hospital of Shantou University Medical College

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma

07/21

07/23

NCT05003245: Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Completed

407

RoW

HLX04-O，recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection, Lucentis

Shanghai Henlius Biotech

Age Related Macular Degeneration

05/24

ALIGN, NCT04573478: Atrasentan in Patients With IgA Nephropathy

Active, not recruiting

404

Europe, Canada, Japan, US, RoW

Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo

Chinook Therapeutics, Inc.

IgA Nephropathy, Immunoglobulin A Nephropathy

12/26

NCT02584478 / 2021-003871-32: Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)

Active, not recruiting

294

Europe, US, RoW

AL3818, Anlotinib Hydrochloride, Anlotinib, Catequentinib, Paclitaxel, Pegylated Liposomal Doxorubicin (PLD), Topotecan, Daily Topotecan, Weekly Topotecan, Carboplatin, Paraplatin, Taxol

Advenchen Laboratories, LLC, Advenchen Laboratories, LLC

Endometrial Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Cervical Carcinoma

10/24

12/24

CMML1-2, NCT06647862: IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia

Recruiting

170

RoW

IMM01, Timdarpacept, Azacitidine, Placebo

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Chronic Myelomonocytic Leukemia

04/26

10/29

NCT06584032: Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer

Recruiting

412

RoW

fruquintinib, HMPL-013, sintilimab, IBI308, paclitaxel, doxorubicin

Hutchmed

Advanced Endometrial Cancer

01/29

06/29

NCT05051891: A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma

Recruiting

356

RoW

Orelabrutinib and R-CHOP, R-CHOP

Beijing InnoCare Pharma Tech Co., Ltd.

Treatment-naїve Mantle Cell Lymphoma

12/24

12/27

NCT05709093: A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)

Terminated

RoW

Lemzoparlimab+Azacitidine (AZA), Azacitidine (AZA)

TJ Biopharma Co., Ltd.

Myelodysplastic Syndromes(MDS)

04/24

TQB2450-II-08, NCT04574284: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer

Completed

170

RoW

TQB2450, Anlotinib

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Advanced Endometrial Cancer

11/23

05/24

NCT04423926: Lenalidomide in Combination With CHOP in Patients With Untreated PTCL

Recruiting

RoW

Lenalidomide, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone

The First Affiliated Hospital with Nanjing Medical University

PTCL, NOS, AITL, ALK- ALCL, Phase III-IV ALK+ ALCL, EATL

12/22

12/24

NCT04859621: Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections

Recruiting

150

RoW

Vitamin D3 4000 IU, Vitamin D3 2000 IU, Placebo, standard antibiotic therapy

Zensun Sci. & Tech. Co., Ltd.

Recurrent Urinary Tract Infection

04/25

07/25

NCT05764590: A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients

Completed

RoW

AP-306, Sevelamer Carbonate

Alebund Pharmaceuticals

Chronic Kidney Diseases, Hyperphosphatemia

08/23

09/23

NCT05662813: Almonertinib Therapy in Patients With Abnormal Liver Function After EGFR-TKI Treatment, or Almonertinib First-line Therapy in Patients With Basic Hepatopathy

Recruiting

RoW

Almonertinib, HS-10296

West China Hospital

Non-small Cell Lung Cancer

12/23

06/25

ACCLAIM, NCT06479759: LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Recruiting

RoW

LM-108 antibody and sintilimab, Trial group 1, LM-108 antibody and sintilimab and chemotherapy, Trial group 2

Shanghai Pulmonary Hospital, Shanghai, China

NSCLC, PD-1

06/25

12/25

NCT06241781: Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients with Recurrent or Metastatic Cervical Cancer

Recruiting

RoW

GT101 injection, Gemcitabine injection

Grit Biotechnology

Adult

01/27

NCT06701357: CR-CHOP+X in Previously Untreated DEL

Recruiting

RoW

CR-CHOP+PD1 inhibitor, CR-CHOP + Orelabrutinib, CR-CHOP + decitabine

Ruijin Hospital

DLBCL

12/26

12/28

NCT04432714: Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement

Recruiting

RoW

Lenalidomide, Rituximab, Etoposide, Doxorubicin, Vincristine, Cyclophosphamide, Prednisone

The First Affiliated Hospital with Nanjing Medical University

DLBCL, Untreated, MYC Gene Rearrangement

12/24

12/26

NCT06750991: CD-RCHOP in ND DLBCL With a Combination of TP53 Mutation and Del(17p)

Not yet recruiting

RoW

CDR-CHOP

Ruijin Hospital

DLBCL

12/26

12/28

TQB3616-II-04, NCT06702618: Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer

Not yet recruiting

RoW

TQB3616 capsule+Fulvestrant Injection

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Breast Cancer

05/26

12/26

NCT06014190: HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer

Recruiting

460

RoW

HS-20089

Hansoh BioMedical R&D Company

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Endometrial Cancer

12/25

12/27

NCT04202003: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

	Efficacy data from trial in combination with azacitidine for MDS
	Sep 2022 - Sep 2022: Efficacy data from trial in combination with azacitidine for MDS
	Data from a study in combination with azacitidine for MDS at ESMO 2022
	Sep 2022 - Sep 2022: Data from a study in combination with azacitidine for MDS at ESMO 2022

Completed

1/2

105

RoW

TJ011133

TJ Biopharma Co., Ltd.

Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes(MDS)

12/23

NCT05551507: IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer

Recruiting

1/2

150

RoW

IN10018 in combination with PLD, IN10018 add on to PLD treatment

InxMed (Shanghai) Co., Ltd.

Platinum-resistant Ovarian Cancer

12/25

NCT05186012: APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

Recruiting

1/2

RoW

APG-1252, Pelcitoclax, Chidamide

Ascentage Pharma Group Inc.

NHL, Adult

09/25

03/26

GLB-001-02, NCT06378437: A Study of GLB-001 in Patients With Myeloid Malignancies

Recruiting

108

RoW

GLB-001, GLB-C183-A-2

Hangzhou GluBio Pharmaceutical Co., Ltd.

Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myeloid Malignancy

12/26

12/27

ICP-CL-01201, NCT05728658: The Study of ICP-248 in Patients with Mature B-cell Malignancies

Recruiting

191

RoW

ICP-248, ICP-248+Orelabrutinib

Beijing InnoCare Pharma Tech Co., Ltd.

Hematological Malignancies

08/25

10/26

MAPLE-1, NCT04260217: APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia

Completed

US, RoW

APG2575 400 mg, APG2575 600 mg, APG2575 800 mg

Ascentage Pharma Group Inc.

Waldenstrom Macroglobulinemia

02/24

NCT05641259: A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML

Recruiting

198

RoW

LP-108, Azacitidine

Guangzhou Lupeng Pharmaceutical Company LTD.

Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia

12/24

12/25

DILI-P, NCT02961413: A Prospective Cohort Study on Drug-induced Liver Injury in China（）

Recruiting

N/A

10000

RoW

Drug Induced Liver Disease Study Group

Drug-induced Liver Injury

12/30

NCT04432402: Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

Recruiting

N/A

124

RoW

Lenalidomide, Rituximab, Gemcitabine, oxaliplatin

The First Affiliated Hospital with Nanjing Medical University

Diffuse Large B Cell Lymphoma

12/22

12/24

NCT04714918: Chinese CKD-MBD Prevalence Survey (CRISS-MBD)

Recruiting

N/A

10254

RoW

Limeng Chen

Chronic Kidney Diseases, Chronic Kidney Disease-Mineral and Bone Disorder

12/24

NCT05119647: A Single-Arm Objective Performance Criteria Trial for Intracranial Thrombus Aspiration Catheter

Completed

N/A

124

RoW

Thrombus Aspiration Catheter(Ton-bridgeMT)

Zhuhai Tonbridge Medical Tech. Co., Ltd.

Acute Ischemic Stroke

08/22

11/22

NCT05208437: Shorten the Time Required to Correct the Arrival of Complete Oral Feeding in Premature Infants

Completed

N/A

148

RoW

Complete oral feeding intervention, Routine nursing care group

Children's Hospital of Fudan University

Premature Infants

06/23

07/23

NCT06188195: Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS

Recruiting

N/A

500

RoW

Dexamethasone, antenatal corticosteroids

The Second Affiliated Hospital of Chongqing Medical University, University-Town Hospital of Chongqing Medical University, Children's Hospital of Chongqing Medical University, Chongqing Medical Center for Women and Children

Acute Respiratory Distress Syndrome, Respiratory Distress Syndrome, Acute

12/25

NCT06232772: Research on Novel Biomarkers for Early Diagnosis of Parkinson's Disease:An Observational, Multicenter, Non-Randomized Controlled Study

Recruiting

N/A

600

RoW

α- Synuclein Ultrafine Fluorescence Detection Method

Yousheng Xiao, The First Affiliated Hospital of Guangzhou Medical University, First Affiliated Hospital, Sun Yat-Sen University, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Guilin Medical College, Guangxi International Zhuang Medical Hospital

Parkinson's Disease

06/26

NCT06703918: Study on Clostridium Difficile Infection in Infants

Recruiting

N/A

150

RoW

First People's Hospital of Hangzhou, Westlake University

Clostridium Difficile Infection

12/26

NCT06676085: A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation

Recruiting

N/A

RoW

Nafamostat, Heparin

Beijing Chao Yang Hospital

ECMO

12/27

LEFAZAREM, NCT04737343: Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis

Recruiting

N/A

114

RoW

Leflunomide, Tuoshu for commericial name, Azathioprine Tablets

Chinese SLE Treatment And Research Group, Shanghai Zhongshan Hospital, Affiliated Hospital of Jilin University, Changchun,China, Second Affiliated Hospital of Nanchang University, The First Affiliated Hospital of Anhui Medical University, Beijing Shijitan Hospital, Capital Medical University, The Affiliated Hospital of Inner Mongolia Medical University, The First Affiliated Hospital of Kunming Medical College, Sichuan Province People's Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University

ANCA Associated Vasculitis, Maintenance Therapy

11/24

12/24

NCT05629819: Effect of Early Non-invasive Phrenic Nerve Stimulation on Weaning in Mechanically Ventilated Patients

Recruiting

N/A

104

RoW

Non-invasive phrenic nerve stimulation

Bing Sun

Mechanical Ventilation, Weaning

12/24

NCT05635760: Parent-implemented Social Communication Treatment in Autism

Active, not recruiting

N/A

112

RoW

Group-based Parent-implemented Social Communication Training, Self-learning-based Parent-implemented Social Communication Training

Chinese University of Hong Kong

Autism, Social Communication, Speech Therapy, Parenting, Autism Spectrum Disorder

11/24

12/25

NCT05987293: A Single-center, Prospective Study for Mechanism and Risk Factors of Tracheal Tube-related Tongue Injury

Active, not recruiting

N/A

RoW

Tracheal tube-tongue pressure is measured using a computerized occlusal analysis system based on T-Scan® technique, suitable for multi-point real-time monitoring of intraoral pressure.

China-Japan Friendship Hospital

Tracheal Tube-related Tongue Injury

08/24

12/25

NCT06016777: Optimization of Perioperative Analgesia Protocol for Uniportal Video-assisted Thoracoscopic Surgery

Recruiting

N/A

102

RoW

Ultrasound-guided paraspinal block and patient-controlled intravenous analgesia pump, Ultrasound-guided erector spinal block and patient-controlled intravenous analgesia pump, Patient-controlled intravenous analgesia pump

China-Japan Friendship Hospital

Uniportal Video-assisted Thoracic Surgery

09/25

10/25

NCT05824988: Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

Recruiting

N/A

100

RoW

Drug exposure

Shanghai Pulmonary Hospital, Shanghai, China, Fudan University, University of Sydney, Karolinska Institutet, Shanghai Municipal Center for Disease Control and Prevention

Mycobacterium Avium Complex, Mycobacterium Avium-Intracellulare Infection, Gram-Positive Bacterial Infections, Mycobacterium Infections

10/25

10/26

HeadSOAR, NCT06115707: Head Position After Endovascular Therapy

Recruiting

N/A

1332

RoW

The lying flat (0°-10°) head position for 72 hours, The The head elevation (30°-40°) position for 72 hours

Zhengzhou Yuan

Stroke, Acute, Endovascular Therapy

11/25

04/26

BEST-BAO, NCT05631847: Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke

Active, not recruiting

N/A

340

RoW

Endovascular treatment, Intravenous thrombolysis (Alteplase)

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis, Alteplase, Endovascular Treatment

09/25

03/26

NCT05148130: Construction and Biological Study of Blood and Placenta Samples Associated With Gestational Diabetes Mellitus

Recruiting

N/A

300

RoW

oral glucose tolerance test

Second Affiliated Hospital, School of Medicine, Zhejiang University

Gestational Diabetes

09/22

09/23

Wei, Dong

NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients

Recruiting

5000

RoW

Peginterferon Alfa-2B, Nucleoside Analogs

Third Affiliated Hospital, Sun Yat-Sen University

Hepatitis B, Chronic

12/26

11/29

NCT06481085: To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Not yet recruiting

318

RoW

HDM1002 50 mg, HDM1002, HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg, HDM1002 200 mg BID, Placebo, Matching placebo for group A to group E

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Type 2 Diabetes

04/25

NCT06633666: Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms

Recruiting

N/A

160

RoW

Acupuncture

Hong Kong Baptist University

Long Covid19, Neuropsychiatric Symptom, Acupuncture

01/26

04/26

NACSOC, NCT02972541: Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer

Recruiting

N/A

248

RoW

Stenting with neoadjuvant chemotherapy, Stenting with immediate Surgery

Beijing Chao Yang Hospital

Colorectal Cancer, Neoadjuvant Chemotherapy, Stent, Obstruction

12/23

NCT06023147: A Real-world Study of the Short-term Efficacy and Safety of E-TACE in Patients With Hepatocellular Carcinoma (HCC)

Not yet recruiting

N/A

298

RoW

E-TACE

Xuhua Duan

Hepatocellular Carcinoma

09/24

09/25

NCT05890508: Electro-acupuncture for Long Covid Neuropsychiatric Symptoms

Recruiting

N/A

150

RoW

Acupuncture, Sham-acupuncture

Hong Kong Baptist University

Long Covid19, Neuropsychiatric Symptoms, Electro-acupuncture

01/26

04/26

BEST-BAO, NCT05631847: Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke

Active, not recruiting

N/A

340

RoW

Endovascular treatment, Intravenous thrombolysis (Alteplase)

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis, Alteplase, Endovascular Treatment

09/25

03/26

Guo, Hai-Zhi

BEST-BAO, NCT05631847: Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke

Active, not recruiting

N/A

340

RoW

Endovascular treatment, Intravenous thrombolysis (Alteplase)

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis, Alteplase, Endovascular Treatment

09/25

03/26

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Wang, Li Yong

DEFORM, NCT05606718: Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Remodeling

Recruiting

RoW

Dapagliflozin, guideline-directed medical therapy (GDMT)

Sun Yat-sen University

Functional Mitral Regurgitation

06/23

07/23

ERSAF, NCT03749057: Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation

Recruiting

400

RoW

Rivaroxaban

General Hospital of Shenyang Military Region

Cerebral Infarction, TIA

11/24

DCAP, NCT04868565: Target Weaning Oxygen to Determine Cafffeine Duration for AOP

Completed

310

RoW

Caffeine Citrate 20 MG/1 ML Intravenous Solution [CAFCIT]

Children's Hospital of Chongqing Medical University

Apnea of Prematurity, Caffeine, Weaning Oxygen, Medicine Regimen

10/23

NCT06461377: The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy

Recruiting

RoW

Glucagon-like peptide-1 receptor agonist：Semaglutide, Semaglutide

The First Affiliated Hospital with Nanjing Medical University

Type 2 Diabetes, Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)

12/26

12/27

NCT06359106: Effects of Different Inhaled Oxygen Concentrations on Lung Function in Older Patients After Laparoscopic Gastrointestinal Surgery Under General Anesthesia

Recruiting

1098

RoW

80% Oxygen, 40% Oxygen

China Medical University, China

Oxygenation Index

12/25

NCT04650243: Clinical Research of Tapering UDCA in PBC Patients with a Complete Response

Recruiting

RoW

ursodeoxycholic acid, UDCA

Peking Union Medical College Hospital

Primary Biliary Cholangitis

05/25

NCT06674226: Effects of Ciprofol on Postoperative Delirium and Outcomes in Elderly Patients Undergoing Major Thoracic Surgery

Recruiting

214

RoW

Ciprofol, Propofol

Postoperative Delirium (POD)

06/26

EM-PD, NCT06928519: Efficacy and Safety of Entacapone Combined With Madopar in the Treatment of Early Parkinson's Disease: An Observational, Multicenter, Case-Control Study

Recruiting

216

RoW

Madopar (levodopa/benserazide), Intervention for Madopar + Entacapone Group

Yousheng Xiao, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Guangxi International Zhuang Medicine Hospital, Ethnic Hospital of Guangxi Zhuang Autonomous Region, Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University

Parkinson Disease (PD)

04/27

06/27

NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting

9000

RoW

Aspirin 100 mg Oral Tablet, Matching Placebo

Guangdong Provincial People's Hospital, The George Institute

CKD (Chronic Kidney Disease) Stage 5D

09/26

12/26

NCT02654561: Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation

Recruiting

600

RoW

Heparin Sodium, Unfractionated heparin, Saline, Normal saline

Sepsis, Disseminated Intravascular Coagulation

12/24

06/25

EHTASEOCCS, NCT03373058: Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery

Recruiting

310

RoW

Hyperthermic Intraperitoneal Chemotherapy, HIPEC, cytoreductive surgery, CRS, adjuvant chemotherapy, ACT

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma

07/21

07/23

NCT05003245: Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Completed

407

RoW

HLX04-O，recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection, Lucentis

Shanghai Henlius Biotech

Age Related Macular Degeneration

05/24

ALIGN, NCT04573478: Atrasentan in Patients With IgA Nephropathy

Active, not recruiting

404

Europe, Canada, Japan, US, RoW

Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo

Chinook Therapeutics, Inc.

IgA Nephropathy, Immunoglobulin A Nephropathy

12/26

Active, not recruiting

294

Europe, US, RoW

AL3818, Anlotinib Hydrochloride, Anlotinib, Catequentinib, Paclitaxel, Pegylated Liposomal Doxorubicin (PLD), Topotecan, Daily Topotecan, Weekly Topotecan, Carboplatin, Paraplatin, Taxol

Advenchen Laboratories, LLC, Advenchen Laboratories, LLC

Endometrial Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Cervical Carcinoma

10/24

12/24

CMML1-2, NCT06647862: IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia

Recruiting

170

RoW

IMM01, Timdarpacept, Azacitidine, Placebo

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Chronic Myelomonocytic Leukemia

04/26

10/29

NCT06584032: Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer

Recruiting

412

RoW

fruquintinib, HMPL-013, sintilimab, IBI308, paclitaxel, doxorubicin

Hutchmed

Advanced Endometrial Cancer

01/29

06/29

Recruiting

356

RoW

Orelabrutinib and R-CHOP, R-CHOP

Beijing InnoCare Pharma Tech Co., Ltd.

Treatment-naїve Mantle Cell Lymphoma

12/24

12/27

Terminated

RoW

Lemzoparlimab+Azacitidine (AZA), Azacitidine (AZA)

TJ Biopharma Co., Ltd.

Myelodysplastic Syndromes(MDS)

04/24

TQB2450-II-08, NCT04574284: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer

Completed

170

RoW

TQB2450, Anlotinib

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Advanced Endometrial Cancer

11/23

05/24

NCT04423926: Lenalidomide in Combination With CHOP in Patients With Untreated PTCL

Recruiting

RoW

Lenalidomide, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone

The First Affiliated Hospital with Nanjing Medical University

PTCL, NOS, AITL, ALK- ALCL, Phase III-IV ALK+ ALCL, EATL

12/22

12/24

NCT04859621: Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections

Recruiting

150

RoW

Vitamin D3 4000 IU, Vitamin D3 2000 IU, Placebo, standard antibiotic therapy

Zensun Sci. & Tech. Co., Ltd.

Recurrent Urinary Tract Infection

04/25

07/25

NCT05764590: A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients

Completed

RoW

AP-306, Sevelamer Carbonate

Alebund Pharmaceuticals

Chronic Kidney Diseases, Hyperphosphatemia

08/23

09/23

NCT05662813: Almonertinib Therapy in Patients With Abnormal Liver Function After EGFR-TKI Treatment, or Almonertinib First-line Therapy in Patients With Basic Hepatopathy

Recruiting

RoW

Almonertinib, HS-10296

West China Hospital

Non-small Cell Lung Cancer

12/23

06/25

ACCLAIM, NCT06479759: LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Recruiting

RoW

LM-108 antibody and sintilimab, Trial group 1, LM-108 antibody and sintilimab and chemotherapy, Trial group 2

Shanghai Pulmonary Hospital, Shanghai, China

NSCLC, PD-1

06/25

12/25

NCT06241781: Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients with Recurrent or Metastatic Cervical Cancer

Recruiting

RoW

GT101 injection, Gemcitabine injection

Grit Biotechnology

Adult

01/27

NCT06701357: CR-CHOP+X in Previously Untreated DEL

Recruiting

RoW

CR-CHOP+PD1 inhibitor, CR-CHOP + Orelabrutinib, CR-CHOP + decitabine

Ruijin Hospital

DLBCL

12/26

12/28

NCT04432714: Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement

Recruiting

RoW

Lenalidomide, Rituximab, Etoposide, Doxorubicin, Vincristine, Cyclophosphamide, Prednisone

The First Affiliated Hospital with Nanjing Medical University

DLBCL, Untreated, MYC Gene Rearrangement

12/24

12/26

NCT06750991: CD-RCHOP in ND DLBCL With a Combination of TP53 Mutation and Del(17p)

Not yet recruiting

RoW

CDR-CHOP

Ruijin Hospital

DLBCL

12/26

12/28

TQB3616-II-04, NCT06702618: Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer

Not yet recruiting

RoW

TQB3616 capsule+Fulvestrant Injection

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Breast Cancer

05/26

12/26

NCT06014190: HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer

Recruiting

460

RoW

HS-20089

Hansoh BioMedical R&D Company

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Endometrial Cancer

12/25

12/27

	Efficacy data from trial in combination with azacitidine for MDS
	Sep 2022 - Sep 2022: Efficacy data from trial in combination with azacitidine for MDS
	Data from a study in combination with azacitidine for MDS at ESMO 2022
	Sep 2022 - Sep 2022: Data from a study in combination with azacitidine for MDS at ESMO 2022

Completed

1/2

105

RoW

TJ011133

TJ Biopharma Co., Ltd.

Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes(MDS)

12/23

NCT05551507: IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer

Recruiting

1/2

150

RoW

IN10018 in combination with PLD, IN10018 add on to PLD treatment

InxMed (Shanghai) Co., Ltd.

Platinum-resistant Ovarian Cancer

12/25

NCT05186012: APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

Recruiting

1/2

RoW

APG-1252, Pelcitoclax, Chidamide

Ascentage Pharma Group Inc.

NHL, Adult

09/25

03/26

GLB-001-02, NCT06378437: A Study of GLB-001 in Patients With Myeloid Malignancies

Recruiting

108

RoW

GLB-001, GLB-C183-A-2

Hangzhou GluBio Pharmaceutical Co., Ltd.

Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myeloid Malignancy

12/26

12/27

ICP-CL-01201, NCT05728658: The Study of ICP-248 in Patients with Mature B-cell Malignancies

Recruiting

191

RoW

ICP-248, ICP-248+Orelabrutinib

Beijing InnoCare Pharma Tech Co., Ltd.

Hematological Malignancies

08/25

10/26

MAPLE-1, NCT04260217: APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia

Completed

US, RoW

APG2575 400 mg, APG2575 600 mg, APG2575 800 mg

Ascentage Pharma Group Inc.

Waldenstrom Macroglobulinemia

02/24

NCT05641259: A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML

Recruiting

198

RoW

LP-108, Azacitidine

Guangzhou Lupeng Pharmaceutical Company LTD.

Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia

12/24

12/25

DILI-P, NCT02961413: A Prospective Cohort Study on Drug-induced Liver Injury in China（）

Recruiting

N/A

10000

RoW

Drug Induced Liver Disease Study Group

Drug-induced Liver Injury

12/30

NCT04432402: Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

Recruiting

N/A

124

RoW

Lenalidomide, Rituximab, Gemcitabine, oxaliplatin

The First Affiliated Hospital with Nanjing Medical University

Diffuse Large B Cell Lymphoma

12/22

12/24

NCT04714918: Chinese CKD-MBD Prevalence Survey (CRISS-MBD)

Recruiting

N/A

10254

RoW

Limeng Chen

Chronic Kidney Diseases, Chronic Kidney Disease-Mineral and Bone Disorder

12/24

NCT05119647: A Single-Arm Objective Performance Criteria Trial for Intracranial Thrombus Aspiration Catheter

Completed

N/A

124

RoW

Thrombus Aspiration Catheter(Ton-bridgeMT)

Zhuhai Tonbridge Medical Tech. Co., Ltd.

Acute Ischemic Stroke

08/22

11/22

NCT05208437: Shorten the Time Required to Correct the Arrival of Complete Oral Feeding in Premature Infants

Completed

N/A

148

RoW

Complete oral feeding intervention, Routine nursing care group

Children's Hospital of Fudan University

Premature Infants

06/23

07/23

NCT06188195: Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS

Recruiting

N/A

500

RoW

Dexamethasone, antenatal corticosteroids

Acute Respiratory Distress Syndrome, Respiratory Distress Syndrome, Acute

12/25

NCT06232772: Research on Novel Biomarkers for Early Diagnosis of Parkinson's Disease:An Observational, Multicenter, Non-Randomized Controlled Study

Recruiting

N/A

600

RoW

α- Synuclein Ultrafine Fluorescence Detection Method

Parkinson's Disease

06/26

NCT06703918: Study on Clostridium Difficile Infection in Infants

Recruiting

N/A

150

RoW

First People's Hospital of Hangzhou, Westlake University

Clostridium Difficile Infection

12/26

NCT06676085: A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation

Recruiting

N/A

RoW

Nafamostat, Heparin

Beijing Chao Yang Hospital

ECMO

12/27

LEFAZAREM, NCT04737343: Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis

Recruiting

N/A

114

RoW

Leflunomide, Tuoshu for commericial name, Azathioprine Tablets

ANCA Associated Vasculitis, Maintenance Therapy

11/24

12/24

NCT05629819: Effect of Early Non-invasive Phrenic Nerve Stimulation on Weaning in Mechanically Ventilated Patients

Recruiting

N/A

104

RoW

Non-invasive phrenic nerve stimulation

Bing Sun

Mechanical Ventilation, Weaning

12/24

NCT05635760: Parent-implemented Social Communication Treatment in Autism

Active, not recruiting

N/A

112

RoW

Group-based Parent-implemented Social Communication Training, Self-learning-based Parent-implemented Social Communication Training

Chinese University of Hong Kong

Autism, Social Communication, Speech Therapy, Parenting, Autism Spectrum Disorder

11/24

12/25

NCT05987293: A Single-center, Prospective Study for Mechanism and Risk Factors of Tracheal Tube-related Tongue Injury

Active, not recruiting

N/A

RoW

Tracheal tube-tongue pressure is measured using a computerized occlusal analysis system based on T-Scan® technique, suitable for multi-point real-time monitoring of intraoral pressure.

China-Japan Friendship Hospital

Tracheal Tube-related Tongue Injury

08/24

12/25

NCT06016777: Optimization of Perioperative Analgesia Protocol for Uniportal Video-assisted Thoracoscopic Surgery

Recruiting

N/A

102

RoW

China-Japan Friendship Hospital

Uniportal Video-assisted Thoracic Surgery

09/25

10/25

NCT05824988: Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

Recruiting

N/A

100

RoW

Drug exposure

Shanghai Pulmonary Hospital, Shanghai, China, Fudan University, University of Sydney, Karolinska Institutet, Shanghai Municipal Center for Disease Control and Prevention

Mycobacterium Avium Complex, Mycobacterium Avium-Intracellulare Infection, Gram-Positive Bacterial Infections, Mycobacterium Infections

10/25

10/26

HeadSOAR, NCT06115707: Head Position After Endovascular Therapy

Recruiting

N/A

1332

RoW

The lying flat (0°-10°) head position for 72 hours, The The head elevation (30°-40°) position for 72 hours

Zhengzhou Yuan

Stroke, Acute, Endovascular Therapy

11/25

04/26

BEST-BAO, NCT05631847: Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke

Active, not recruiting

N/A

340

RoW

Endovascular treatment, Intravenous thrombolysis (Alteplase)

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis, Alteplase, Endovascular Treatment

09/25

03/26

NCT05148130: Construction and Biological Study of Blood and Placenta Samples Associated With Gestational Diabetes Mellitus

Recruiting

N/A

300

RoW

oral glucose tolerance test

Second Affiliated Hospital, School of Medicine, Zhejiang University

Gestational Diabetes

09/22

09/23

Wei, Dong

NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients

Recruiting

5000

RoW

Peginterferon Alfa-2B, Nucleoside Analogs

Third Affiliated Hospital, Sun Yat-Sen University

Hepatitis B, Chronic

12/26

11/29

NCT06481085: To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Not yet recruiting

318

RoW

HDM1002 50 mg, HDM1002, HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg, HDM1002 200 mg BID, Placebo, Matching placebo for group A to group E

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Type 2 Diabetes

04/25

NCT06633666: Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms

Recruiting

N/A

160

RoW

Acupuncture

Hong Kong Baptist University

Long Covid19, Neuropsychiatric Symptom, Acupuncture

01/26

04/26

NACSOC, NCT02972541: Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer

Recruiting

N/A

248

RoW

Stenting with neoadjuvant chemotherapy, Stenting with immediate Surgery

Beijing Chao Yang Hospital

Colorectal Cancer, Neoadjuvant Chemotherapy, Stent, Obstruction

12/23

NCT06023147: A Real-world Study of the Short-term Efficacy and Safety of E-TACE in Patients With Hepatocellular Carcinoma (HCC)

Not yet recruiting

N/A

298

RoW

E-TACE

Xuhua Duan

Hepatocellular Carcinoma

09/24

09/25

NCT05890508: Electro-acupuncture for Long Covid Neuropsychiatric Symptoms

Recruiting

N/A

150

RoW

Acupuncture, Sham-acupuncture

Hong Kong Baptist University

Long Covid19, Neuropsychiatric Symptoms, Electro-acupuncture

01/26

04/26

BEST-BAO, NCT05631847: Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke

Active, not recruiting

N/A

340

RoW

Endovascular treatment, Intravenous thrombolysis (Alteplase)

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis, Alteplase, Endovascular Treatment

09/25

03/26

Guo, Hai-Zhi

BEST-BAO, NCT05631847: Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke

Active, not recruiting

N/A

340

RoW

Endovascular treatment, Intravenous thrombolysis (Alteplase)

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis, Alteplase, Endovascular Treatment

09/25

03/26

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites